Lee Ainslie Agios Pharmaceuticals, Inc. Transaction History

Maverick Capital LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$29.58 - $49.78 $797,476 - $1.34 Million	-26,960 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$41.92 - $58.18 $1.13 Million - $1.57 Million	26,960 New	26,960 $1.24 Million
Q2 2021 Aug 16, 2021	SELL	$52.06 - $61.27 $210,426 - $247,653	-4,042 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$44.23 - $57.5 $165,729 - $215,452	3,747 Added 1270.17%	4,042 $209,000
Q4 2020 Feb 16, 2021	BUY	$33.21 - $46.54 $9,796 - $13,729	295 New	295 $13,000

232

58.1M

403K

469K

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $2.99B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

Get notified when there are updates to the investment portfolio of Maverick Capital LTD, based on Form 13F filings with the SEC.

Stay updated on Maverick Capital LTD and Lee Ainslie with notifications on news.